Structures by: Rubčić M.
Total: 78
Bis[2-(3-pyridinium)-2'-(2-hydroxynaphthyl)-(carbonylbis(hydrazin-2-yl-1-ylidenemethylylidene)] hexamolybdate dihydrate
Mo6O19,2(C18H16N5O2),2(H2O)
New Journal of Chemistry (2020) 44, 31 13357-13367
a=9.7786(3)Å b=16.9721(4)Å c=14.4712(4)Å
α=90° β=104.582(3)° γ=90°
3-[(E)-[(1-hydroxyphenyl-2-yl)methylidene]amino]-1-[(E)-[(pyridin-3-yl)methylidene]amino]urea
C14H13N5O2
New Journal of Chemistry (2020) 44, 31 13357-13367
a=20.1878(10)Å b=6.1088(3)Å c=23.5694(13)Å
α=90° β=90° γ=90°
3-[(E)-[(1-hydroxyphenyl-2-yl)methylidene]amino]-1-[(E)-[(pyridin-3-yl)methylidene]amino]urea hydrate
C14H13N5O2,H2O
New Journal of Chemistry (2020) 44, 31 13357-13367
a=6.3767(6)Å b=7.7407(7)Å c=30.099(3)Å
α=90° β=93.079(8)° γ=90°
3-[(E)-[(1-hydroxynapthalen-2-yl)methylidene]amino]-1-[(E)-[(pyridin-3-yl)methylidene]amino]urea hemimethanol solvate
2(C18H15N5O2),CH4O
New Journal of Chemistry (2020) 44, 31 13357-13367
a=9.2562(9)Å b=12.8021(9)Å c=30.334(3)Å
α=90° β=95.858(9)° γ=90°
(mu-N''-(2-oxynaphthylidene)-N'''-(3-pyridinium)carbonohydrazido)(N-acetonitrile)-dioxomolybdenum(vi) hexamolybdate acetonitrile solvate
C20H18MoN6O4,2(Mo3O9.5),2(C2H3N)
New Journal of Chemistry (2020) 44, 31 13357-13367
a=45.012(7)Å b=11.4125(5)Å c=21.787(4)Å
α=90° β=134.52(3)° γ=90°
3-[(E)-[(1-hydroxynapthalen-2-yl)methylidene]amino]-1-[(E)-[(pyridin-3-yl)methylidene]amino]urea hemihydrate
2(C18H15N5O2),H2O
New Journal of Chemistry (2020) 44, 31 13357-13367
a=8.4843(7)Å b=12.7276(8)Å c=31.583(2)Å
α=90° β=92.519(7)° γ=90°
3-[(E)-[(1-hydroxyphenyl-2-yl)methylidene]amino]-1-[(E)-[(pyridin-4-yl)methylidene]amino]urea
C14H13N5O2
New Journal of Chemistry (2020) 44, 31 13357-13367
a=7.7355(5)Å b=9.1187(5)Å c=9.7039(5)Å
α=93.758(5)° β=93.790(5)° γ=92.877(5)°
(mu-N''-(2-oxybenzylidene)-N'''-(3-pyridyl)carbonohydrazido)(O-methanol)-dioxomolybdenum(vi)
C15H15MoN5O5
New Journal of Chemistry (2020) 44, 31 13357-13367
a=7.7443(3)Å b=19.3301(6)Å c=11.3770(3)Å
α=90° β=91.632(3)° γ=90°
Bis((mu-N''-(2-oxybenzylidene)-N'''-(3-pyridyl)carbonohydrazido))-tetraoxo-di-molybdenum(vi) acetonitrile solvate
C28H22Mo2N10O8,2(C2H3N)
New Journal of Chemistry (2020) 44, 31 13357-13367
a=11.3525(9)Å b=13.6312(8)Å c=12.5586(8)Å
α=90° β=116.102(9)° γ=90°
Bis[2-(4-pyridinium)-2'-(2-hydroxynaphthyl)-(carbonylbis(hydrazin-2-yl-1-ylidenemethylylidene)] hexamolybdate
Mo6O19,2(C18H16N5O2)
New Journal of Chemistry (2020) 44, 31 13357-13367
a=9.3887(3)Å b=17.2816(5)Å c=14.7114(6)Å
α=90° β=105.236(4)° γ=90°
2,2'-(carbonylbis(hydrazin-2-yl-1-ylidenemethylylidene))di(3-methoxyphenolato))bis(methanol)tetraoxo-di-molybdenum(vi)methanol solvate
C19H22Mo2N4O11,0.64(CO)
New Journal of Chemistry (2020) 44, 19 8085-8097
a=7.4466(4)Å b=13.8570(9)Å c=14.0640(8)Å
α=112.516(5)° β=98.637(4)° γ=97.085(5)°
2,2'-(carbonylbis(hydrazin-2-yl-1-ylidenemethylylidene)) di(3-methoxyphenolato))bis(imidazol)tetraoxo-di-molybdenum(vi) acetonitrile solvate
C23H22Mo2N8O9,C2H3N
New Journal of Chemistry (2020) 44, 19 8085-8097
a=8.2715(3)Å b=12.1751(5)Å c=15.0901(5)Å
α=85.958(3)° β=87.645(3)° γ=81.166(3)°
1,3-bis[(E)-[(2-hydroxy-4-methoxyphenyl)methylidene]amino]urea
C17H18N4O5
New Journal of Chemistry (2020) 44, 19 8085-8097
a=9.3305(8)Å b=10.2881(7)Å c=18.0461(16)Å
α=90° β=104.692(8)° γ=90°
2,2'-(carbonylbis(hydrazin-2-yl-1-ylidenemethylylidene))di(4-methoxyphenolato))bis(imidazol)tetraoxo-di-molybdenum(vi)acetonitrile solvate
C23H22Mo2N8O9,2(C2H3N)
New Journal of Chemistry (2020) 44, 19 8085-8097
a=8.6152(4)Å b=13.1856(7)Å c=15.5721(8)Å
α=75.325(4)° β=74.393(4)° γ=85.158(4)°
2,2'-(carbonylbis(hydrazin-2-yl-1-ylidenemethylylidene))di(4-methoxyphenolato))bis(methanol)tetraoxo-di-molybdenum(vi)
C19H22Mo2N4O11
New Journal of Chemistry (2020) 44, 19 8085-8097
a=7.4676(3)Å b=11.7394(4)Å c=14.8772(6)Å
α=105.949(3)° β=103.394(3)° γ=96.009(3)°
Methanol(2-oxobenzaldehyde 2-aminobenzoylhydrazonato-O,N,O')dioxomolybdenum(VI)
C15H15MoN3O5
New Journal of Chemistry (2019) 43, 14 5531
a=11.5800(8)Å b=9.6323(4)Å c=14.7642(10)Å
α=90° β=107.415(7)° γ=90°
Cyclo-bis(2-oxobenzaldehyde 2-aminobenzoylhydrazonato-O,N,O',N')tetraoxo-dimolybdenum(VI)
C14H11MoN3O4
New Journal of Chemistry (2019) 43, 14 5531
a=8.1665(5)Å b=9.6856(4)Å c=18.1363(11)Å
α=90° β=94.776(6)° γ=90°
Cyclo-bis(2-oxo-4-methoxybenzaldehyde 2-aminobenzoylhydrazonato-O,N,O\#8217;,N\#8217;)tetraoxo-dimolybdenum(VI)
C15H13MoN3O5
New Journal of Chemistry (2019) 43, 14 5531
a=12.1433(13)Å b=9.9365(5)Å c=12.6523(12)Å
α=90° β=98.553(9)° γ=90°
Cyclo-bis(2-oxo-4-methoxybenzaldehyde 2-aminobenzoylhydrazonato-O,N,O\#8217;,N\#8217;)tetraoxo-dimolybdenum(VI)/acetonitrile (1/2)
C15H13MoN3O5,C2H3N
New Journal of Chemistry (2019) 43, 14 5531
a=8.1916(4)Å b=9.2854(5)Å c=12.5130(5)Å
α=79.025(4)° β=89.996(3)° γ=74.990(4)°
Cyclo-bis(2-oxobenzaldehyde 2-aminobenzoylhydrazonato-O,N,O',N')tetraoxo-dimolybdenum(VI)
C28H22Mo2N6O8
New Journal of Chemistry (2019) 43, 14 5531
a=12.5190(10)Å b=18.4290(6)Å c=12.9998(8)Å
α=90° β=114.273(8)° γ=90°
Cyclo-bis(2-oxo-4-methoxybenzaldehyde 2-aminobenzoylhydrazonato-O,N,O',N')tetraoxo-dimolybdenum(VI)
C15H13MoN3O5
New Journal of Chemistry (2019) 43, 14 5531
a=8.0972(3)Å b=9.5153(2)Å c=20.0124(5)Å
α=90° β=90.318(3)° γ=90°
Methanol(2-oxo-4-methoxybenzaldehyde 2-aminobenzoylhydrazonato-O,N,O')dioxo molybdenum(VI)
C16H17MoN3O6
New Journal of Chemistry (2019) 43, 14 5531
a=12.9814(7)Å b=9.8022(4)Å c=14.1346(7)Å
α=90° β=106.969(5)° γ=90°
4-oxopimelic acid 4,4'-bipyridine
C7H10O5,C10H8N2
New Journal of Chemistry (2011) 35, 1 24
a=15.8717(3)Å b=9.4064(2)Å c=17.3535(4)Å
α=90.00° β=140.5120(10)° γ=90.00°
4-oxo-heptane-1,7-dioic acid 4,4'-bipyridine
C7H10O5,C10H8N2
New Journal of Chemistry (2011) 35, 1 24
a=7.583(3)Å b=8.752(2)Å c=24.527(6)Å
α=90.00° β=92.29(3)° γ=90.00°
C14H13N3O2
C14H13N3O2
CrystEngComm (2018) 20, 13 1804
a=20.911(2)Å b=5.3366(5)Å c=10.8719(9)Å
α=90° β=90° γ=90°
C14H13N3O3,CH4O
C14H13N3O3,CH4O
CrystEngComm (2018) 20, 13 1804
a=8.7634(6)Å b=19.3464(11)Å c=8.8479(7)Å
α=90° β=96.305(7)° γ=90°
C15H15N3O3,CH4O
C15H15N3O3,CH4O
CrystEngComm (2018) 20, 13 1804
a=18.819(2)Å b=12.3035(8)Å c=15.245(2)Å
α=90° β=113.799(16)° γ=90°
C15H17N3O4
C15H17N3O4
CrystEngComm (2018) 20, 13 1804
a=24.185(3)Å b=12.6631(18)Å c=4.7046(8)Å
α=90° β=90° γ=90°
C15H15N3O3
C15H15N3O3
CrystEngComm (2018) 20, 13 1804
a=9.8994(7)Å b=6.8199(3)Å c=20.3396(15)Å
α=90° β=90° γ=90°
C17H21N3O4
C17H21N3O4
CrystEngComm (2018) 20, 13 1804
a=19.2494(10)Å b=12.8121(6)Å c=15.0103(7)Å
α=90° β=112.476(6)° γ=90°
C14H13N3O3,CH4O
C14H13N3O3,CH4O
CrystEngComm (2018) 20, 13 1804
a=15.6285(5)Å b=12.4516(4)Å c=7.3947(3)Å
α=90° β=93.187(3)° γ=90°
C15H15N3O3
C15H15N3O3
CrystEngComm (2018) 20, 13 1804
a=11.9715(5)Å b=12.5059(6)Å c=9.3710(4)Å
α=90° β=97.453(4)° γ=90°
C2H19CoMoN6O11
C2H19CoMoN6O11
CrystEngComm (2018) 20, 13 1889
a=27.0371(12)Å b=7.9845(3)Å c=6.4776(3)Å
α=90° β=90° γ=90°
C16H46Co2Mo2N8O28
C16H46Co2Mo2N8O28
CrystEngComm (2018) 20, 13 1889
a=10.7699(5)Å b=22.3609(9)Å c=15.1262(8)Å
α=90° β=90° γ=90°
C8Mo4O28,2(C2H2MoO8),4(CoH18N6),10(H2O)
C8Mo4O28,2(C2H2MoO8),4(CoH18N6),10(H2O)
CrystEngComm (2018) 20, 13 1889
a=10.2131(3)Å b=13.1299(4)Å c=13.2356(3)Å
α=79.390(2)° β=84.259(2)° γ=77.997(2)°
C18H64Co2Mo3N12O29
C18H64Co2Mo3N12O29
CrystEngComm (2018) 20, 13 1889
a=13.5465(3)Å b=11.6910(3)Å c=28.9847(7)Å
α=90° β=90° γ=90°
C4H4Mo2O15,2(C6H16CoN4O4),4(H2O)
C4H4Mo2O15,2(C6H16CoN4O4),4(H2O)
CrystEngComm (2018) 20, 13 1889
a=12.8719(10)Å b=10.4734(7)Å c=14.5744(10)Å
α=90° β=112.997(8)° γ=90°
C14H48Co2MoN8O23
C14H48Co2MoN8O23
CrystEngComm (2018) 20, 13 1889
a=10.0883(12)Å b=11.9280(13)Å c=15.268(4)Å
α=67.802(7)° β=86.402(2)° γ=75.040(10)°
C20H60Co2Mo4N12O33
C20H60Co2Mo4N12O33
CrystEngComm (2018) 20, 13 1889
a=13.5099(10)Å b=17.5536(10)Å c=9.9621(8)Å
α=90° β=87.737(6)° γ=90°
C8H2Mo4O28,2(CoH18N6),6(H2O)
C8H2Mo4O28,2(CoH18N6),6(H2O)
CrystEngComm (2018) 20, 13 1889
a=10.5531(3)Å b=16.1106(6)Å c=23.2787(7)Å
α=90° β=90° γ=90°
Cis-dioxo(N-3-methoxysalicylidene-2-amino -3- hydroxypyridine)(propanol)molybdenum(VI)
C16H18MoN2O6
CrystEngComm (2011) 13, 13 4314
a=7.7894(4)Å b=10.0907(7)Å c=12.5937(5)Å
α=86.293(4)° β=81.553(4)° γ=69.096(5)°
Cis-dioxo(N-3-methoxysalicylidene-2-amino-3-hydroxypyridine) (4-methylpyridine)molybdenum(VI) acetonitrile solvate
C19H17MoN3O5,C2H3N
CrystEngComm (2011) 13, 13 4314
a=8.8879(3)Å b=14.5134(5)Å c=16.4716(6)Å
α=90.00° β=90.433(3)° γ=90.00°
(Imidazole)cis-dioxo(N-3-methoxysalicylidene-2-amino -3- hydroxypyridine)molybdenum(VI) acetonitrile solvate
C16H14MoN4O5,C2H3N
CrystEngComm (2011) 13, 13 4314
a=7.5668(3)Å b=19.3973(7)Å c=14.5305(6)Å
α=90.00° β=116.626(3)° γ=90.00°
(4,4'-bipyridine)bis(cis-dioxo(N-3-methoxysalicylidene -2- amino-3-hydroxypyridine))dimolybdenum(VI) dichlormethane solvate
C36H28Mo2N6O10,2(CH2Cl2)
CrystEngComm (2011) 13, 13 4314
a=12.3420(12)Å b=13.4804(9)Å c=17.3437(16)Å
α=90.00° β=131.638(6)° γ=90.00°
(Ethanol)cis-dioxo(N-3-methoxysalicylidene-2-amino -3- hydroxypyridine)molybdenum(VI)
C15H16MoN2O6
CrystEngComm (2011) 13, 13 4314
a=8.0992(16)Å b=11.4036(11)Å c=17.993(3)Å
α=90.00° β=99.474(16)° γ=90.00°
(Imidazole)cis-dioxo(N-3-methoxysalicylidene -2-amino-3- hydroxypyridine)molybdenum(VI)
C16H14MoN4O5
CrystEngComm (2011) 13, 13 4314
a=7.4565(4)Å b=17.8707(14)Å c=12.2079(9)Å
α=90.00° β=93.021(6)° γ=90.00°
Ethoxo-oxo-(salicylaldehydehyde 4-phenylthiosemicarbazonato(2- ))vanadium(V)
C16H16N3O3SV
Dalton Transactions (2009) 44 9914-9923
a=10.8123(2)Å b=9.8588(2)Å c=16.0968(4)Å
α=90.00° β=102.663(2)° γ=90.00°
Oxo-propoxo-(salicylaldehyde 4-phenylthiosemicarbazonato(2- ))vanadium(V)
C17H18N3O3SV
Dalton Transactions (2009) 44 9914-9923
a=15.1837(4)Å b=8.0325(2)Å c=16.0582(5)Å
α=90.00° β=114.404(4)° γ=90.00°
Diethoxo-μ-oxo-dioxobis[2-(5-phenylamino-[1,3,4]thiadiazol-2-yl)-phenolato]divanadium(V)
C32H30N6O7S2V2
Dalton Transactions (2009) 44 9914-9923
a=11.4910(9)Å b=11.8518(9)Å c=14.7813(13)Å
α=92.462(7)° β=100.455(7)° γ=118.288(8)°
Dimethoxo-μ-oxo-dioxobis[2-(5-phenylamino-[1,3,4]thiadiazol-2-yl)-phenolato]divanadium(V) methanol hemisolvate
C30H26N6O7S2V2,0.5(CH4O)
Dalton Transactions (2009) 44 9914-9923
a=11.8680(19)Å b=11.963(2)Å c=14.3202(9)Å
α=102.100(10)° β=96.852(8)° γ=119.640(19)°
Diethoxo-μ-oxo-dioxobis[2-(5-phenylamino-[1,3,4]thiadiazol-2-yl)-phenolato]divanadium(V) ethanol hemisolvate
C32H30N6O7S2V2,0.5(C2H6O)
Dalton Transactions (2009) 44 9914-9923
a=11.6448(4)Å b=12.1611(4)Å c=14.4691(5)Å
α=73.441(3)° β=84.791(3)° γ=62.827(3)°
Μ-oxo-dioxobis[2-(5-phenylamino-[1,3,4]thiadiazol-2-yl)-phenolato]-dipropoxo-divanadium(V) propanol hemisolvate
C34H34N6O7S2V2,0.5(C3H8O)
Dalton Transactions (2009) 44 9914-9923
a=13.4762(5)Å b=17.2325(7)Å c=17.0544(6)Å
α=90.00° β=101.835(4)° γ=90.00°
Bis[2-(4-pyridinium)-2'-(2-hydroxyphenyl)-(carbonylbis(hydrazin-2-yl-1-ylidenemethylylidene)] hexamolybdate
Mo6O19,2(C14H14N5O2)
New Journal of Chemistry (2020) 44, 31 13357-13367
a=9.1525(5)Å b=17.7564(7)Å c=13.2831(9)Å
α=90° β=106.419(7)° γ=90°
[2,2'-(carbonylbis(hydrazin-2-yl-1-ylidenemethylylidene))diphenolato]bis(methanol)tetraoxo-di-molybdenum(vi)
C17H18Mo2N4O9
New Journal of Chemistry (2020) 44, 19 8085-8097
a=7.2762(3)Å b=11.2625(3)Å c=25.8472(7)Å
α=88.871(2)° β=86.314(3)° γ=89.709(2)°
2,2'-(carbonylbis(hydrazin-2-yl-1-ylidenemethylylidene))di(3-methoxyphenolato))bis(methanol)tetraoxo-di-molybdenum(vi)methanol solvate
C19H22Mo2N4O11,CH4O
New Journal of Chemistry (2020) 44, 19 8085-8097
a=9.6337(5)Å b=11.0989(6)Å c=13.1012(8)Å
α=112.619(5)° β=98.807(5)° γ=94.858(4)°
2,2'-(carbonylbis(hydrazin-2-yl-1-ylidenemethylylidene))diphenolato)bis(imidazol)tetraoxo-di-molybdenum(vi)) acetonitrile solvate
C21H18Mo2N8O7,C2H3N
New Journal of Chemistry (2020) 44, 19 8085-8097
a=8.6920(4)Å b=26.7430(8)Å c=11.6059(4)Å
α=90° β=96.219(4)° γ=90°
(Methanol)cis-dioxo(N-3-methoxysalicylidene-2-amino-3 - hydroxypyridine)molybdenum(VI)
C14H14MoN2O6
CrystEngComm (2011) 13, 13 4314
a=8.1890(7)Å b=10.9898(9)Å c=17.930(2)Å
α=90.00° β=105.346(9)° γ=90.00°
(4,4'-bipyridine)bis(cis-dioxo(N-3-methoxysalicylidene -2- amino-3-hydroxypyridine))dimolybdenum(VI)
C36H28Mo2N6O10
CrystEngComm (2011) 13, 13 4314
a=11.7871(6)Å b=12.8269(7)Å c=13.8071(6)Å
α=108.490(5)° β=94.104(4)° γ=113.811(5)°
4-methoxysalicylaldehyde 4-hydroxybenzhydrazone
C15H14N2O4
RSC Adv. (2015)
a=15.1547(3)Å b=8.3437(2)Å c=10.9630(2)Å
α=90° β=101.307(2)° γ=90°
3-methoxysalicylaldehyde benzhydrazone
C15H14N2O3
RSC Adv. (2015)
a=9.1617(5)Å b=6.1414(4)Å c=23.4795(12)Å
α=90° β=94.806(5)° γ=90°
(2-oxy-3-methoxybenzaldehyde 4-hydroxybenzoylhydrazonato-O,N,O) (2-oxy-3-methoxybenzaldehyde 4-hydroxybenzoylhydrazidato-O,N,O) cobalt(III) methanol solvate (1/0.7)
C30.72H25CoN4O8.72
RSC Adv. (2015)
a=10.1424(6)Å b=12.2350(10)Å c=13.1652(8)Å
α=102.995(6)° β=107.619(5)° γ=96.756(6)°
(2-oxybenzaldehyde 4-hydroxybenzoylhydrazonato-O,N,O) (2-oxybenzaldehyde 4-hydroxybenzoylhydrazidato-O,N,O)cobalt(III)
C28H21CoN4O6
RSC Adv. (2015)
a=11.5874(6)Å b=18.9530(9)Å c=23.1420(14)Å
α=90° β=90° γ=90°
4-methoxysalicylaldehyde benzhydrazone
C15H14N2O3
RSC Adv. (2015)
a=11.4472(6)Å b=12.6502(9)Å c=9.4907(5)Å
α=90° β=97.657(5)° γ=90°
(2-oxy-3-methoxybenzaldehyde 4-hydroxybenzoylhydrazonato-O,N,O) (2-oxy-3-methoxybenzaldehyde 4-hydroxybenzoylhydrazidato-O,N,O) cobalt(III)
C30H25CoN4O8
RSC Adv. (2015)
a=10.2428(4)Å b=12.2495(4)Å c=13.1323(6)Å
α=102.594(3)° β=107.080(4)° γ=97.463(3)°
(2-oxy-4-methoxybenzaldehyde benzoylhydrazonato-O,N,O) (2-oxy-4-methoxybenzaldehyde benzoylhydrazidato-O,N,O) cobalt(III) methanol solvate (1/1)
C31H25CoN4O7
RSC Adv. (2015)
a=21.903(4)Å b=10.2910(8)Å c=12.5225(8)Å
α=90° β=98.436(10)° γ=90°
Memantinium mesylate
C12H22N,CH3O3S
Acta Crystallographica Section E (2019) 75, 8 1274-1279
a=11.7761(2)Å b=11.8731(2)Å c=18.2788(3)Å
α=92.501(2)° β=94.696(2)° γ=116.609(2)°
Salicylaldehyde 4-phenylthiosemicarbazone
C14H13N3OS
Acta Crystallographica Section C (2008) 64, 10 o570-o573
a=10.6328(3)Å b=11.1114(3)Å c=12.8839(10)Å
α=75.251(5)° β=65.652(2)° γ=81.539(2)°
4-methoxysalicylaldehyde 4-phenylthiosemicarbazone
C15H15N3O2S1
Acta Crystallographica Section C (2008) 64, 10 o570-o573
a=4.73851(17)Å b=11.3244(4)Å c=14.0775(5)Å
α=78.390(3)° β=89.547(3)° γ=89.364(3)°
1,5-bis(salicylidene)carbohydrazide
C15H14N4O3
Crystal Growth & Design (2014) 14, 6 2900
a=10.5804(12)Å b=15.7399(18)Å c=9.0114(11)Å
α=90.00° β=97.649(11)° γ=90.00°
1,5-bis(salicylidene)carbohydrazide
C15H14N4O3
Crystal Growth & Design (2014) 14, 6 2900
a=9.4272(14)Å b=10.3890(15)Å c=14.370(3)Å
α=90.00° β=102.477(2)° γ=90.00°
1,5-bis(salicylidene)carbohydrazide monohydrate
C15H14N4O3,H2O
Crystal Growth & Design (2014) 14, 6 2900
a=4.5443(5)Å b=12.2026(15)Å c=27.359(4)Å
α=90.00° β=90.00° γ=90.00°
1,5-bis(salicylidene)carbohydrazide
C15H14N4O3
Crystal Growth & Design (2014) 14, 6 2900
a=14.5908(6)Å b=9.3764(4)Å c=10.3283(3)Å
α=90.00° β=90.00° γ=90.00°
1-{2-[(2-Hydroxy-4-methoxy-benzylidene)-hydrazono]-4-methyl-3-phenyl- -2,3-dihydro-thiazol-5-yl}-ethanone
C20H19N3O3S
Crystal Growth & Design (2011) 11, 12 5227
a=9.5280(4)Å b=10.0721(4)Å c=10.5449(3)Å
α=95.344(3)° β=110.811(4)° γ=95.371(4)°
Ethoxo-(4-methoxysalicylaldehyde-4-phenylthiosemicarbazonato(2-))- oxo-vanadium(V)
C17H18N3O4SV
Crystal Growth & Design (2011) 11, 12 5227
a=12.4255(3)Å b=15.7746(4)Å c=18.5559(5)Å
α=90.00° β=96.510(2)° γ=90.00°
Propoxo-(4-methoxysalicylaldehyde-4-phenylthiosemicarbazonato(2-))- oxo-vanadium(V)
C18H20N3O4SV
Crystal Growth & Design (2011) 11, 12 5227
a=12.3684(3)Å b=15.9862(4)Å c=19.1848(5)Å
α=90.00° β=97.975(2)° γ=90.00°
Propoxo-(4-methoxysalicylaldehyde-4-phenylthiosemicarbazonato(2-))- oxo-vanadium(V)
C18H20N3O4SV
Crystal Growth & Design (2011) 11, 12 5227
a=9.7545(11)Å b=12.9941(14)Å c=30.452(3)Å
α=88.183(8)° β=80.838(9)° γ=89.875(9)°
Methoxo-(4-methoxysalicylaldehyde-4-phenylthiosemicarbazonato(2-))- oxo-vanadium(V)
C16H16N3O4SV
Crystal Growth & Design (2011) 11, 12 5227
a=12.2897(5)Å b=10.3757(4)Å c=16.3811(9)Å
α=90.00° β=125.598(3)° γ=90.00°
Ethoxo-(4-methoxysalicylaldehyde-4-phenylthiosemicarbazonato(2-))- oxo-vanadium(V)
C17H18N3O4SV
Crystal Growth & Design (2011) 11, 12 5227
a=7.2239(11)Å b=9.693(2)Å c=13.592(3)Å
α=87.323(18)° β=86.732(15)° γ=71.447(17)°